Pay in 4 interest-free payments of $28.26 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
JAK2 inhibitor AZD1480 inhibits JAK2 activation
Formula: C5H11NO2S
Nupercainal hydrochloride
PubMed PMID: 27696405
we temporally name it as MDK-0264
PHA-848125 - CAS# 802539-81-7 Catalog No.:M10691-10 JAK2 inhibitor AZD1480 inhibits JAK2Milciclib, also known as PHA 848125 or PHA 848125AC, is an orally bioavailable inhibitor of cyclin dependent kinases (CDKs) and thropomyosin receptor kinase A (TRKA), with potential antineoplastic activity. CDK2 TRKA inhibitor PHA 848125 AC potently inhibits cyclin dependent kinase 2 (CDK2) and exhibits activity against other CDKs including CDK1 and CDK4, in addition to TRKA. Inhibition of these kinases may result in cell cycle arrest and apoptosis of
US$ 26.00
US$ 65.00
US$ 395.00
US$ 29.99
US$ 71.95